International Journal of Immunology is a peer-reviewed open access journal that publishes original research articles as well as review articles in all areas of immunology. Immunology is a diverse and growing discipline that can be defined as the study of the tissues, cells and molecules involved in host defense mechanisms. Immunologists attempt to understand how the immune system develops, how the body defends itself against disease, and what happens when it all goes wrong. Priority is given to work that provides fundamental insight into the workings of the immune system. Areas covered include, but are not limited to, innate immunity and inflammation; development; immune receptors, signaling and apoptosis; antigen presentation; gene regulation and recombination; cellular and systemic immunity; vaccines; immune tolerance; autoimmunity and tumor immunology, microbial immunopathology; and transplantation.
The great advances in immunology in recent years make this field one of the most dynamic and rapidly growing in biological sciences. This remarkable growth is stimulated by the influx of investigators from other disciplines such as biochemistry, genetics, molecular biology, microbiology, virology and various medical disciplines. These disciplines are so well interlinked with immunology that no immunological challenge can now be properly addressed without sophisticated applications of expertise of combinations of these disciplines. As a consequence, immunology has become a vast and rich field encompassing discoveries and outlooks that range from the highly clinical to the highly molecular. Although such perspectives may appear diverse, they are, in fact, extremely interdependent. The journal seeks to present a balanced overview of contemporary immunology and melds together different aspects of molecular immunology, immunobiology and clinical immunology.
Immunology is the branch of biomedical science that deals with the response of an organism to antigenic challenge and its recognition of what is self and what is not. It deals with the defense mechanisms including all physical, chemical and biological properties of the organism that help it to combat its susceptibility to foreign organisms, material, etc
Immunology has its origins in the study of how the body protects itself against infectious diseases caused by microorganisms, such as bacteria, viruses, protozoa, and fungi, and also parasitic organisms, such as helminth worms. Research / review articles deals with, among other things, the physiological functioning of the immune system in states of both health and disease; malfunctions of the immune system in immunological disorders (autoimmune diseases, hypersensitivities, immune deficiency, transplant rejection); the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo are of prime interest.
We take great pleasure in welcoming you to our new journal, International Journal of Immunology. We have created this publication with the intention of providing a space for the generation of knowledge, dialogue, critique, debate, and collaboration among an international community of immunologists, pathologists, researchers, scholars, etc.
Our vision is to create a high-quality publication that will be relevant, challenging, thought-provoking, for graduate students, academic researchers and scholars. We welcome original research papers, reviews articles, case studies, book reviews, and works-in progress.
We look forward to welcoming your submissions.
1. Adaptive immunity 11. Cancer and Tumor Immunobiology
2. Immunologic Techniques 12. Cellular & Regional Immunology
3. Transplantation Immunology 13. Combining Cancer Immunotherapies
4. Computational Immunology 14. Allergy prevention and risk factors
5. Immunology 15. Nutritional Immunology
6. Immunotherapy 16. Clinical Immunology
7. Pediatric Immunology 17. Reproductive Immunology
8. Immune Tolerance 18. Fungal Immunology
9. Mucosal Immunology 19. Neuro Immunology
10. Immune Toxicology 20.Immunoinformatics and System
Immune Scientific Networks:
Immunology Leadership & Committees consider proposals for Special Issues Editors will return a decision on your proposal within Two weeks of receipt. To enrich our vision of making the scientific information available at an ease of access, Immunology Leadership & Committees initiated special issue for the open access journals. All the articles published under a special issue focuses on a single topic providing the complete information about the ongoing research providing more insight on an emphasized topic of research enabling the readers access wide forecasted information on a particular topic Issue.
Special Issue Proposals: Special Issue deals with focused research topics of high interest, falling under the scope of the Journal. Special Issues are the pool of articles under a current topic selected from the Ongoing Research under specific discipline. The aim of the Special Issue is to provide a platform for the researchers to understand the recent advancements and challenges in particular areas of research. These articles will provide an opportunity to the readers to understand and access the scientific information.
We encourage potential scientists to organize the Special Issue in their field of interests that fits within the Journal scope. This will provide an opportunity to increase the visibility of the Guest Editors. The Special Issue Titles may be from any basic and clinical area of Science, Technology and Medicine. People interested in publishing a special issue are advised to consider the following guidelines.
Your proposal should contain:
By submitting a Special Issue proposal to Immunology Leadership & Committees, you agree to abide by the Special Issue Editor Protocol should your proposal be accepted
Special issue articles are published immediately upon their acceptance and are released under upcoming regular issues. Special Issues are invited throughout the year. For more information or any queries about the special issues, please write us to email@example.com or firstname.lastname@example.org
Promoting Your Special Issue
Immunology Leadership & Committees will work with Guest Editors to increase the visibility of the Special Issue in the months leading up to the submission deadline and once it has been published.
What Immunology Leadership & Committees will do:
1. Immunology Leadership & Committees will circulate your Call for Papers to the Immune Editorial Board, targeted mailing lists, and relevant AoM listservs. It will also advertise your Call on the Immune websites and other social media platforms. It will re-issue the Call at appropriate intervals.
2. Once the Special Issue is published, announcements will be made to the Immune Editorial Board, targeted mailing lists, and relevant AoM listservs as well as on the Immune websites social media platforms.
3. Free access to the Special Issue will be made available in the website to Guest Editors and readers.
What is expected of Guest Editors?
1. We expect that Guest Editors will circulate the Call for Papers within their own personal networks, social media groups, and at any relevant conferences or workshops they may attend.
2. If it has not already been suggested as part of the proposal, consideration should be given to organizing a conference or workshop either to generate submissions or to aid in the development of submitted papers. A symposium or PDW at a well-known conference may also be considered.
3. We expect Guest Editors to identify up to 50 scholars for whom the Special Issue will be particularly relevant
If you have any queries, please contact Elena Griffin (email@example.com)
I am a competent and experienced Paediatrician with an extensive clinical background in General Paediatrics. He is very dedicated to a career within paediatric with an interest in paediatric infectious diseases and child public health. Over the last year, he has gained excellent experience in management of complex paediatric cases in St. George’s Hospital London and Queen Elizabeth Hospital, London. I am involved in a number of research projects and currently working on an Enhanced National Surveillance of Pneumococcal Meningitis in England and Wales.
Mar’ 2017 CCT in General Paediatrics
Jun’2015 MSc in Paediatricsand Child Health
Imperial College, London
May’ 2012 MRCPCH (UK)
Royal College of Paediatrics and Child Health
May’ 2005 Diploma in Computer Studies
University of Ado-Ekiti, Ekiti. Nigeria
Apr’ 2000 MBBS
University of Ilorin, Ilorin. Nigeria.
PRIZES AND AWARDS
Nov. 2017, winner of the British Paediatric Surveillance Unit (BPSU) Award for the study of pneumococcal Meningitis
Dec. 2004, Merit Award, Best Doctor of the Year, F.M.C., Ekiti State, Nigeria
Nov’ 2002, Merit Award, Quality Improvement Project, NYSC, Ekiti State, Nigeria
MEMBERSHIP OF PROFESSIONAL ORGANISATIONS
Member Royal College of Paediatrics and Child Health
Member European Society of Paediatric Infectious Diseases
Member of the British Medical Association
Member of the Medical Protection Society (MDU)
Member of the American Public Health Association (APHA)
Oligbu G, Collins S et al. Impact of pneumococcal conjugate vaccine on pneumococcal meningitisin England and Wales, 2000/01-2015/16. (Manuscriptssubmitted to Lancet)
Oligbu GI, Fallaha M, Pay L, Ahmed L, Oligbu OE, Saroey P.Risk of seizure following Zika Virus infection in children. 2017. Developmental Medicine & Child Neurology, 59: 39–136. doi: 10.1111/dmcn.13623
Pay L, Fallaha M, Oligbu OE, Ahmed L, Durojaiye CO, Oligbu GI. Zika virus associated meningoencephalitis in children; Are we under reporting?2017. Developmental Medicine & Child Neurology, 59: 39–136. doi: 10.1111/dmcn.13623
Fallaha M, Pay L, Ahmed L, Adepoju A, Oligbu GI. Risk of Transverse myelitis following Zika Virus infection.2017. Developmental Medicine & Child Neurology, 59: 39–136. doi: 10.1111/dmcn.13623
Oligbu G, Collins S et al. Significant declines in childhood pneumococcal meningitis rates following routine conjugate vaccination in England and Wales, 2000/01-2015/16. 35th Annual meeting of the European Society for Paediatric Infectious Disease. 10th – 14thMay, 2016. Brighton, England.
Oligbu, G., et al. "Characteristics and serotype distribution of childhood cases of invasive pneumococcal disease following pneumococcal conjugate vaccination in England and Wales, 2006-14." Clinical Infectious Diseases (2017).
Godwin Oligbu, IndulaBopitiya, Praveen Saroey,AtraAyad.SclerosingAngiomatoid Nodular Transformation of the Spleen in Children: A case report and review of the literature. Archives of infectious diseases and therapy 2017; 2(2) 24-26.
N Tanna, G Oligbu, M Boullier, M Blair. Vitamin D Mobile Healthcare Applications for Consumer Use - Are They Any Good?. Journal of Food and Nutrition Research.Vol. 5, No. 7, 2017, pp 522-530.
Oligbu G, Collins S, Streetly A, et al. Risk of invasive pneumococcal disease in children with sickle cell disease in england: National observational cohort study, 2010 – 2015.
Archives of Disease in Childhood 2017;102:A4.
Godwin Oligbu, Sarah Collins, Carmen L. Sheppard, Norman K. Fry, Mary Slack, Ray Borrow, Shamez N. Ladhani; Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006–2014. Clin Infect Dis 2017; 65 (2): 308-314.
Araujo R, Oligbu G, Cleugh F, et al. Are qi methods useful in the design and delivery of a blended learning programme?Archives of Disease in Childhood 2017;102:A10.
Godwin Oligbu et al. SclerosingAngiomatoid Nodular Transformation of the Spleen: An unusual finding in paediatric population.J Genet Syndr Gene Ther 2017, 8:2(Suppl)DOI: 10.4172/2157-7412-C1-01
Oligbu G, Dragoumi P, Karuvattil R, et al. Effectiveness of vagus nerve stimulation on patients with complex epilepsy in south east of england, 2008 – 2013. Archives of Disease in Childhood 2017;102:A154-A155.
Tanna N, Oligbu G, Boullier M, et al. Vitamin D mobile healthcare applications (APPS) for consumer use. Archives of Disease in Childhood 2017;102:A58.
Godwin Oligbu et al. Cerebrospinal fluid Pleocytosis following Meningococcal B vaccination in an Infant.35th Annual meeting of the European Society For Paediatric Infectious Disease. 23rd – 27thMay, 2017. Madrid, Spain.
Oligbu G et al. Revisiting Rickets – Are we under-reporting. Faculty of Public Health Annual Conference and Public Health Expo, 20th - 21st June 2017. International Centre, Telford, UK
Mitch Blair, Godwin Oligbu et al. Outside the borders of the hospital- are community pharmacies an untappedresource for parents of children with minor illness. Faculty of Public Health Annual Conference and Public Health Expo, 20th - 21st June 2017. International Centre, Telford, UK
Tanna N, Boullier M, Oligbu G, et al. Can smartphone apps help to address vitamin D deficiency in children? Archives of Disease in Childhood 2017;102:A14.
L Ahmed, A Hargadon-Lowe, S Sahi, G Oligbu.Staphylococcal Toxic Shock Syndrome Followed by Sacrifices.FoundationYears Journal 2017,vol.11(1)s. p 73
S Shah, A Thirunavukarasu, G Oligbu. Early Recognition Of Subtle Seizures In Neonatal Meningitis Makes A Difference To The Outcome.Foundation Years Journal 2017: vol. 11(1)s p 65
Oligbu G, Hsia Y, Folgori L, Collins S, Ladhani S. Pneumococcal conjugate vaccine failure in children: A systematic review of the literature.Vaccine 34(50). November 2016.
Oligbu, G. I., et al. "Pneumococcal conjugate vaccine failure in children younger than 5 years old in England and Wales, 2006–14." Archives of Disease in Childhood 101.Suppl 1 (2016).
Oligbu G, Tewari R, Chopra T, Gabbott E, Caulfield A, Tanna N, Blair M. Optimising bone health and Vitamin D in the community - insights from a community pharmacy survey. Osteoporosis Int2016:27(S2):S670-1
Saroey P, Oligbu G et al. Pott’s Puffy Tumours in Children – Is it really Rare?34th Annual meeting of the European Society For Paediatric Infectious Disease. 10th – 14thMay, 2016. Brighton, England.
Busari, Olusegun, OlusogoBusari, Oligbu Godwin, and Anthony Ajayi. "Novel structured teaching of HIV patients in resource-limiting settings: effects of learning outcomes on adherence to highly active antiretroviral therapy, hospitalization, immunologic recovery and mortality." Journal of Behavioral Health4, no. 2 (2015): 44-48.
Dragoumi P, Oligbu G et al: Myoclonic epilepsy in infancy.It is presented as a possible epilepsy with myoclonic atonic seizures after long-term. 9th Congress Epilepsy - Athens 17-19 October 2014
Busari, O., G. Oligbu, O. Busari, D. Asham, and A. Adeyemi."Effect of structured systematic (modular) teaching of HIV/AIDS patients on adherence to antiretroviral therapy (HAART): report from a national HIV/AIDS treatment centre in sub-Saharan Africa."In 4th Annual HIV Treatment Adherence Conference of the International Association of Providers in AIDS Care, pp. 5-7. 2009.
Busari, O. A., and G. Oligbu. "Chorea in a 29-year-old Nigerian following antimalarial treatment with artesunate."International Journal of Infectious Diseases 12.2 (2008): 221-223.
Busari, O., G. Oligbu, and HIV Study Group."Effect of a novel behavioural intervention to promote condom use among female sex workers along Lagos, Nigeria-Cotonou, Benin international border."15th Conference on Retroviruses and Opportunistic Infections, February. 2008.
Busari OA, Oligbu GI. Willingness to Participate in HIV Vaccine Trial in a Resource-Poor Urban Setting: Is there any Difference between Professionals and Artisans?. In AIDS RESEARCH AND HUMAN RETROVIRUSES 2008 Oct 1 (Vol. 24, pp. 61-61).
Busari OA, Oligbu GI, Busari AA. Assessment of Willingness to Participate in HIV Vaccine Trials in a Cohort of Men Who Have Sex with Men in a Resource-Poor Urban Setting in Nigeria. InAIDS RESEARCH AND HUMAN RETROVIRUSES 2008 Oct 1 (Vol. 24, pp. 59-60).
AO. Ajayi, GI. Oligbu. Knowledge and perception of stroke among at risk medical outpatients in F. M. C. Ido- Ekiti.Annals of African Journal of Medicine (2007)
OA. Busari, GI Oligbu. Structured systematic teaching of HIV/Aids patients: Effects of learning outcomes on self-care, morbidity and hospitalization.Abstract # 930, 13th conference on Retroviruses and opportunistic infections. Denver, U.S.A. Feb. 5-8, 2006.
OA. Busari, GI Oligbu. Community preparedness for Microbicide trial in Resource-Poor Areas.Microbicide 2006, 23-26 April 2006 Cape Town, South Africa.
OA. Busari, GI Oligbu. Impact of Religious Leaders and institutions on Recruitment and retention of microbicide trial participants.Microbicide 2006, 23-26 April 2006 Cape Town, South Africa.
OA Busari, GI Oligbu. Methods of securing male involvement partners consent in microbicide trial. Our experience in a resource-limited area.Microbicide 2006, 23-26 April 2006. Cape Town, South Africa.
Ajayi AO, Agboola SM, Oligbu GI, Ogunmoroti O, Ogunyemi D. Perception of stroke among patients with stroke.Nigerian Medical Practitioner. 2005;48(2):56-8.
‘The Effect of Computer Networking in Ado-Ekiti’.Dissertation written for the award of Diploma in Computer Studies, University of Ado-Ekiti, Nigeria. May.2005
‘Utilization of Health Facility by people of Kuntu Community of Kwara’ Dissertation written for the award of MBBS 2000, University of Ilorin, Nigeria
WHO project, ‘Incidence of Polio in Patigi, Kwara State’ Dissertation written for the award of first MB 1997, University of Ilorin, Nigeria